TGFB1 and neoplasm: A high expression of TGFβ1 was associated with poor survival compared with lower TGFβ1 expressing tumours; 5-year survival among patients with a lower TGFβ1 expression was 70%, whereas >50% of the patients with higher TGFβ1 expression succumbed to their disease in this period (Fig. 6e).